La précaution dans l’innovation en matière de médicaments et de vaccins (notice n° 313633)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 02145cam a2200241 4500500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250117233155.0 |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | fre |
042 ## - AUTHENTICATION CODE | |
Authentication code | dc |
100 10 - MAIN ENTRY--PERSONAL NAME | |
Personal name | Hocquet-Berg, Sophie |
Relator term | author |
245 00 - TITLE STATEMENT | |
Title | La précaution dans l’innovation en matière de médicaments et de vaccins |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Date of publication, distribution, etc. | 2020.<br/> |
500 ## - GENERAL NOTE | |
General note | 37 |
520 ## - SUMMARY, ETC. | |
Summary, etc. | La présente contribution analyse le rôle du principe de précaution lorsque des médicaments ou des vaccins exposent les patients à un risque d’atteintes corporelles. S’il était pleinement consacré en droit de la responsabilité civile, le principe de précaution permettrait de faire peser sur les laboratoires pharmaceutiques, non seulement la charge des dommages que les médicaments ou les vaccins causent, mais encore celle des risques graves et irréversibles, même scientifiquement incertains, auxquels ils exposent les patients, ce qui peut sembler injuste. L’examen du droit positif montre cependant que le principe de précaution a d’ores et déjà contribué à assouplir les conditions de la responsabilité civile en matière de médicaments et de vaccins. |
520 ## - SUMMARY, ETC. | |
Summary, etc. | This paper discusses the role of the precautionary principle when drugs or vaccines put patients at risk of physical damage. If it were fully established in tort law, the precautionary principle would allow pharmaceutical companies to place the burden not only of the damage caused by drugs or vaccines, but also of the hazards – serious and irreversible, even if scientifically uncertain – to which they put the patients, which may seem unfair. A study of positive law shows, however, that the precautionary principle has already contributed to lowering the conditions of civil liability in the area of drugs and vaccines. |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | causalité |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | Médicament |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | vaccin |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | responsabilité civile |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | faute |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | préjudice |
786 0# - DATA SOURCE ENTRY | |
Note | Archives de philosophie du droit | 62 | 1 | 2020-05-20 | p. 341-347 | 0066-6564 |
856 41 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-archives-de-philosophie-du-droit-2020-1-page-341?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-archives-de-philosophie-du-droit-2020-1-page-341?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux